Financials American Well Corporation

Equities

AMWL

US03044L1052

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-05-16 pm EDT 5-day change 1st Jan Change
0.4862 USD +1.57% Intraday chart for American Well Corporation -5.13% -67.37%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,951 1,570 779.4 428.5 144.1 - -
Enterprise Value (EV) 1 4,910 823.7 240.9 56.44 -105.3 -63.05 -56.66
P/E ratio -11.2 x -8.75 x -2.86 x -0.63 x -0.6 x -1.06 x -1.75 x
Yield - - - - - - -
Capitalization / Revenue 24.3 x 6.21 x 2.81 x 1.65 x 0.55 x 0.44 x 0.39 x
EV / Revenue 20 x 3.26 x 0.87 x 0.22 x -0.4 x -0.19 x -0.15 x
EV / EBITDA -53 x -6.71 x -1.37 x -0.34 x 0.67 x 1.04 x 2.35 x
EV / FCF -42.4 x -5.8 x -1.25 x -0.35 x 0.6 x 1.1 x -4.93 x
FCF Yield -2.36% -17.3% -80% -290% 167% 90.9% -20.3%
Price to Book 4.88 x 1.28 x 0.74 x 0.93 x 0.5 x 0.68 x 0.83 x
Nbr of stocks (in thousands) 234,956 259,959 275,410 287,569 296,463 - -
Reference price 2 25.33 6.040 2.830 1.490 0.4862 0.4862 0.4862
Announcement Date 3/24/21 2/24/22 2/22/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 148.9 245.3 252.8 277.2 259 261.7 324 366.2
EBITDA 1 - -92.69 -122.7 -175.3 -165.4 -157.9 -60.79 -24.14
EBIT 1 - -219 -179.1 -275.9 -692.1 -249.4 -153.7 -107.8
Operating Margin - -89.3% -70.87% -99.51% -267.19% -95.29% -47.43% -29.42%
Earnings before Tax (EBT) 1 - -225.8 -179 -269.7 -672.7 -240.8 -148.2 -103.4
Net income 1 -87.19 -224.4 -176.3 -270.4 -675.2 -237.9 -139.5 -81.48
Net margin -58.57% -91.51% -69.76% -97.56% -260.63% -90.88% -43.05% -22.25%
EPS 2 -2.119 -2.270 -0.6900 -0.9900 -2.380 -0.8050 -0.4605 -0.2772
Free Cash Flow 1 - -115.8 -142.1 -192.6 -163.6 -175.9 -57.3 11.49
FCF margin - -47.21% -56.21% -69.49% -63.15% -67.22% -17.68% 3.14%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 8/24/20 3/24/21 2/24/22 2/22/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 72.75 64.23 64.52 69.21 79.2 64 62.45 61.92 70.68 59.52 61.86 64.4 75.77 75.19 78.5
EBITDA 1 -41.09 -47.14 -42.8 -41.9 -43.4 -44.6 -45.3 -38.54 -36.9 -45.65 -39.82 -36.85 -35.45 -17.07 -14.77
EBIT 1 -47.42 -70.48 -69.4 -71.12 -64.84 -67.01 -67.23 -64.47 -56.96 -75.03 -59.73 -57.44 -56.48 -37.99 -36.33
Operating Margin -65.19% -109.73% -107.58% -102.77% -81.87% -104.71% -107.66% -104.11% -80.58% -126.06% -96.56% -89.2% -74.54% -50.53% -46.27%
Earnings before Tax (EBT) 1 -47.21 -70.37 -69.19 -69.89 -60.83 -396.4 -92.17 -135.4 -48.78 -71.25 -56.69 -54.98 -55.78 -38.42 -35.6
Net income 1 -47.79 -70.04 -69.14 -70.08 -61.16 -397.7 -92.48 -136.4 -48.59 -72.1 -57 -54.01 -54.5 -35.77 -32.44
Net margin -65.69% -109.04% -107.17% -101.26% -77.23% -621.38% -148.09% -220.3% -68.75% -121.14% -92.13% -83.87% -71.93% -47.58% -41.32%
EPS 2 -0.1800 -0.2600 -0.2500 -0.2500 -0.2200 -1.420 -0.3300 -0.4800 -0.1700 -0.2500 -0.1950 -0.1830 -0.1842 -0.1198 -0.1091
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/24/22 5/9/22 8/4/22 11/7/22 2/22/23 5/3/23 8/2/23 11/1/23 2/14/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - 1,042 746 539 372 249 207 201
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -116 -142 -193 -164 -176 -57.3 11.5
ROE (net income / shareholders' equity) - -47.1% -13.5% -23.5% -88.4% -54.1% -43.2% -36.8%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - 5.200 4.730 3.840 1.610 0.9700 0.7100 0.5900
Cash Flow per Share 2 - -1.140 -0.5600 -0.7000 -0.5200 -0.4600 -0.0700 -
Capex 1 - 3.32 0.56 0.29 0.19 10.5 8.36 6.96
Capex / Sales - 1.35% 0.22% 0.11% 0.07% 4.03% 2.58% 1.9%
Announcement Date 8/24/20 3/24/21 2/24/22 2/22/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
0.4862 USD
Average target price
1.828 USD
Spread / Average Target
+275.93%
Consensus
  1. Stock Market
  2. Equities
  3. AMWL Stock
  4. Financials American Well Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW